Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04032847
Title ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Achilles Therapeutics UK Limited
Indications

lung non-small cell carcinoma

Therapies

ATL001 + Pembrolizumab

ATL001

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.